Physician’s Profile

Steven J. Lobritto, MD

1
Top Doctor: 
1
Medical Director, Pediatric Liver Transplantation, NewYork-Presbyterian/Columbia
Affiliations: 
NewYork-Presbyterian/Columbia
NewYork-Presbyterian/Morgan Stanley Children's Hospital
Board Certificates: 
Pediatric Transplant Hepatology
Pediatric Gastroenterology
Expertise: 
Hepatitis
Endoscopy
Pediatric Inflammatory Bowel Disease (IBD)
Pediatric Short Bowel Syndrome
Biliary Disease
Endoscopic Feeding Tube Placement
Small Bowel Problem
Intestinal Surgery
Liver Disease In Children
Pediatric Gastrointestinal (GI) Endoscopy
Liver Transplantation
Living Donor Transplantation
Abdominal Organ Transplantation
Liver Transplant, Pediatric
Honors: 
Alpha Omega Alpha Medical Honor Society
Interests: 
Hepatitis B and C treatment in children
Non-alcoholic related fatty liver disease
Novel immunosuppression approaches in pediatric liver transplantation
Treatment and management of intestinal failure induced liver injury
Publications: 
Salame E, Goldstein MJ, Kinkhabwala M, Kapur S, Finn R, Lobritto S, Brown R Jr., Emond JC: Model for end stage liver disease and Child-Turcotte-Pugh scores as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl. 2002, March 8(3):278-84
Nasr SH, Lobritto SJ, Lauring BP, Arend LJ< D’agati VD, Markowitz,GS: A rare complicationof monoclonalgammopathy. AM J Kidney Dis. 2002 Oct. 40(4):867-71.
Robert S. Brown, Jr., K. Shiva Kumar, Mark W. Russo, Milan Kinkhabwala, Diane L. Rudow, Patricia Harren, Steven J. Lobritto, Jean C. Emond: Model for End Stage Liver Disease and Child-Turcotte-Pugh Score as Predictors of Pretransplantation Disease Severity, Postransplantation Outcome, and Resource Utilization in United Network for Organ Sharing Status 2A Patients. Liver Transplantation, Vol 8, No3 (March), 2002: pp 278-284